Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape
Radiotherapy (RT) has been widely used in the clinical treatment of cancers, but radiotherapy resistance (RR) leads to RT failure, tumor recurrence and metastasis. Many studies have been performed on the potential mechanisms behind RR, and a strong link has been found between RR and DNA damage. RT-i...
Main Authors: | Qiu Yuyue, Hu Xinru, Zeng Xiaoping, Wang Hongmei |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2022-10-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2022153 |
Similar Items
-
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
by: Ahmed Elkamhawy, et al.
Published: (2021-06-01) -
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy
by: Santu Saha, et al.
Published: (2022-09-01) -
DNA Repair Inhibitors Potentiate Fractionated Radiotherapy More Than Single-Dose Radiotherapy in Breast Cancer Cells
by: Wen-Kyle Wong, et al.
Published: (2022-08-01) -
Radiotherapy plus CAR-T cell therapy to date: A note for cautions optimism?
by: Tian Huan, et al.
Published: (2022-11-01) -
The emerging role of exosomes in radiotherapy
by: Zhenyi Yang, et al.
Published: (2022-10-01)